
















|
 |
 |
 |
| |
 |

Functionalised
poly(vinyl alcohol)s for biomedical applications |
|
1. Macromolecular drugs
The growing problem of bacterial resistance to conventional
antibiotics and the paucity of effective antiviral agents
both point to the need for new approaches to the treatment
of microbial infections. For instance, studies have demonstrated
that polyvalent compounds, such as polymers bearing pendant
N-acetylneuraminic acid groups, bind influenza virus with
association constants that are several orders of magnitude
higher than those of monomeric N-acetylneuraminic acid derivatives.
This phenomenon is referred to as "polyvalent effect".
|
|



|
|

Figure
1. Structure of the influenza A vibrion [Cartoon from J. S.
Oxford and R. Lambkin Drug Discovery Today 1998, 3, 448-456]
and the N-Acetylneuramic acid molecule (b).
The aim of the project is to synthesise new saccharide containing
polymers able to bind key receptors on viruses and other pathogenic
microbes' surfaces. The resulting inhibition is expected to
be several orders of magnitude higher than those of monomeric
anti microbial agents.

|
|
2.
Hydrogels for tissue engineering and replacement
We are applying our expertise in living radical polymerisation
techniques with the chemoenzymatic synthesis of functionalised
monomers to design polymers with controlled architecture and
bearing complex functionalities of biological relevance. The
aim is to produce highly immune-compatible hydrogels for cartilage
replacement, wound dress and cell delivery.
|
|
|
Figure
2. Scheme of two typical tissue engineering approaches. From
K. Y. Lee and D. J. Mooney Chemical Reviews 2001, 101, 1869-1879.
|
|
|
 |
 |
 |
|

|